What is OptimizeRx's EV / sales?

OptimizeRx (OPRX) reported EV / sales of 1.1× in Q1 2026.

How has OptimizeRx's EV / sales changed year-over-year?

OptimizeRx's EV / sales decreased by 50.8% year-over-year, from 2.3× to 1.1×.

What is the long-term trend for OptimizeRx's EV / sales?

Over 5 years (2020 to 2025), OptimizeRx's EV / sales has grown at a -30.0% compound annual growth rate (CAGR), from 12.6× to 2.1×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

OptimizeRx OPRX EV / sales

EV / sales at other companies

Veeva SystemsVEEV

7.1×-5.2×

PhreesiaPHR

1.3×-1.9×

DoximityDOCS

6.3×-12.4×

GoodRx Holdings, Inc.GDRX

1.2×-1.2×

PubMaticPUBM

1×-0.3×

Spectral AI, Inc.MDAI

2.4×+1.6×

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Calculated from OptimizeRx’s reported figures.

enterprise value/total revenue=1.1×

Based on the most recent quarter.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's EV / sales?: OptimizeRx (OPRX) reported EV / sales of 1.1× in Q1 2026.
How has OptimizeRx's EV / sales changed year-over-year?: OptimizeRx's EV / sales decreased by 50.8% year-over-year, from 2.3× to 1.1×.
What is the long-term trend for OptimizeRx's EV / sales?: Over 5 years (2020 to 2025), OptimizeRx's EV / sales has grown at a -30.0% compound annual growth rate (CAGR), from 12.6× to 2.1×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.